This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Friday, September 22, 2017
In the Battle Against Hepatitis C, the VA Takes the Lead
In the Battle Against Hepatitis C, the VA Takes the Lead By Laura Klivans
No comments:
Post a Comment